< Back

Society for Immunotherapy of Cancer (SITC) Annual Meeting 2018

Nov 18, 2018

November 2018, Washington, D.C.
Abstract: BETATRAP, a replication competent type 5 adenovirus carrying a TGF-beta trap, reverses resistance to a PD-L1 inhibitor in an immunocompetent mouse model